The HDC platform shouldn't have any value ascribed to it yet. Not a single conjugate is in trials yet, and SNTA hasn't even given us a rough timeline as to when the first trial will begin.
Believe it is over 900 patents. You'll have to check the website or simply search on the net.
The HDC platform doesn't seem to have any value yet in the eyes of the market. The large number of drug products that are being patented by SNTA should eventually hold huge value. Whenever a partnership or other deal with just one of the HDC platform drugs occurs, the value of SNTA will just skyrocket. One partnership with the potential for 400 others will open eyes of the analysts and move the share price of SNTA tremendously. Holding long in SNTA should one day prove to be a very lucrative move...it will take some time but when it happens...it will be phenomenal.
Sentiment: Strong Buy
If you are looking for news on revenue, might want to check back in about a year or two for now. This is a clinical stage story...
Why the state of emergency declared in Toledo is good news for OGNG and its cutting edge water harvesting products. Traders brace for the price and volume upgrades.
Think they will let new CEO have some good news to announce as she takes the helm if there is something to communicate between now and then...but would love to wake up one morning to something very positive. Only thing I am anticipating is the Phase 3 criteria for the AML clinical trails.
By the 15th, the 13-F filings should be posted for holders of record, 30-June, although, and probably by design, we'll learn more about who has been accumulating shares through the various shelves after 3Q close (since a good majority of those shares were purchased on and after 03-July.
Is there any news or updates we should be anticipating between now and Labor Day?
Thanks for the article.There appears to be a little good news on the horizon.
Looking at SNTA's charts over a three and one year period,I am seeing the BB's contract in a tightness I have not seen.There is more of a positive MACD convergence too
That could be the price to the upside or downside.I believe it has already reached it's bottom.
IMO,mgmt may give some interesting news in a week or less.
Sentiment: Strong Buy
Thanks for sharing, good stuff. Like you, I'm long this until the end. And at the very least I want short term cap gains-- that means at least through next May. Keep the sensible updates coming.
See attached links
Article 1: A Little Dated, but comes from a CEO Series hosted at Rutgers about 2 years ago which echoes the point made from Gollust on the CC re: leadership
“That’s how I spend a lot of my time, really looking at how I can create an environment, a culture, where our employees can be fully engaged. That happens, I think, through leadership that really tries to connect and genuinely connects with their employees in a conversation. It’s not just one way communication and telling them where we’re going. It’s giving my view and engaging in a dialogue with them, really listening to what their concerns are, listening to what their ideas are and engaging them in the solution. And so, then once you’ve really got a plan, aligning them around it, aligning them in a way that you have to make some difficult choices, you have to clear away some of the work to make room for innovation. That’s sometimes hard for people to do. It’s hard for them to let go of the work they’ve done in the past and what’s made them successful and then step forward to innovate, but you’ve got to create that environment so they can take those risks.”
Article 2: Doesn't provide much information, but thought the paragraph below was useful
Whitaker certainly has experience navigating challenging turnarounds. She was hired by Sanofi three years ago amid a host of threats to that company's diabetes franchise, not the least of which was impending competition from rival insulinmakers and biosimilars. Whitaker helped Sanofi diversify its product portfolio, adding a range of new diabetes devices and apps, such as the iPhone-connected glucose monitor iBGStar.